A three-year study of GA Depot, a monthly injection for primary progressive multiple sclerosis (PPMS), found that most patients experienced no disability progression, with some even showing slight improvements in mobility. These interim results from a Phase 2a clinical trial will be presented tomorrow by developer Mapi Pharma…
ACTRIMS
Multiple Sclerosis News Today is providing virtual coverage of the ACTRIMS Forum 2026, taking place Feb. 5-7 in San Diego. Stay tuned to this page for all the latest news.
Researchers and clinicians are gathering in San Diego and online for the 11th annual Americas Committee for Treatment and Research in Multiple Sclerosis (ACTRIMS) Forum, a three-day meeting focused on multiple sclerosis (MS) research and care. ACTRIMS 2026, being held Feb. 5-7 at the Marriott Marquis San Diego…
Recommended Posts
- Ironically, cutting out coffee gave me a boost of energy
- MS Awareness Month events highlight advocacy, education, fundraising
- I’m going to be more open about my invisible scars from MS
- Having parents who smoked increases risk of pediatric MS: Study
- Ocrevus and Tysabri appear to work equally well to control relapsing MS